ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

被引:63
作者
Ledermann, J. A. [1 ]
Matias-Guiu, X. [2 ,3 ,4 ]
Amant, F. [5 ,6 ]
Concin, N. [7 ,8 ]
Davidson, B. [9 ,10 ]
Fotopoulou, C. [11 ]
Gonzalez-Martin, A. [12 ,13 ]
Gourley, C. [14 ]
Leary, A. [15 ]
Lorusso, D. [16 ,17 ]
Banerjee, S. [18 ,19 ]
Chiva, L. [20 ]
Cibula, D. [21 ,22 ]
Colombo, N. [23 ,24 ]
Croce, S. [25 ]
Eriksson, A. G. [10 ,26 ]
Falandry, C. [27 ,28 ]
Fischerova, D. [21 ,22 ]
Harter, P. [8 ,29 ]
Joly, F. [30 ]
Lazaro, C. [31 ]
Lok, C. [6 ]
Mahner, S. [29 ,32 ]
Marme, F. [29 ,33 ,34 ]
Marth, C. [7 ]
McCluggage, W. G. [35 ]
Mcneish, I. A. [11 ]
Morice, P. [36 ]
Nicum, S. [1 ]
Oaknin, A. [37 ]
Perez-Fidalgo, J. A. [38 ]
Pignata, S. [39 ]
Ramirez, P. T. [40 ]
Ray-Coquard, I. [41 ]
Romero, I. [42 ]
Scambia, G. [16 ,17 ]
Sehouli, J. [43 ,44 ]
Shapira-Frommer, R. [45 ]
Sundar, S. [46 ,47 ]
Tan, D. S. P. [48 ,49 ,50 ,51 ]
Taskiran, C. [38 ]
van Driel, W. J. [40 ]
Vergote, I. [52 ]
Planchamp, F. [37 ]
Sessa, C. [48 ,49 ,50 ,51 ]
Fagotti, A. [6 ]
机构
[1] UCL, UCL Canc Inst, Dept Oncol, London, England
[2] CIBERONC, Madrid, Spain
[3] Univ Lleida, Hosp Univ Arnau Vilanova, Dept Pathol, IRBLLEIDA, Lleida, Spain
[4] Univ Barcelona, Hosp Univ Bellvitge, Dept Pathol, IDIBELL, Barcelona, Spain
[5] Univ Hosp Leuven, Leuven Canc Inst, Dept Gynaecol Oncol, Leuven, Belgium
[6] Netherlands Canc Inst, Ctr Gynecol Oncol Amsterdam, Dept Gynecol, Amsterdam, Netherlands
[7] Med Univ Innsbruck, Dept Obstet & Gynaecol, Innsbruck, Austria
[8] Evang Kliniken Essen Mitte, Dept Gynaecol & Gynaecol Oncol, Essen, Germany
[9] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway
[10] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway
[11] Imperial Coll London, Fac Med, Dept Surg & Canc, London, England
[12] Clin Univ Navarra, Canc Ctr, Dept Med Oncol, Madrid, Spain
[13] Clin Univ Navarra, Canc Ctr, Program Solid Tumours Cima, Madrid, Spain
[14] Univ Edinburgh, Inst Genet & Canc, Canc Res UK Scotland Ctr, Edinburgh, Midlothian, Scotland
[15] Inst Gustave Roussy, Dept Med, Villejuif, France
[16] Fdn Policlin Univ A Gemelli IRCCS, Div Gynecol Oncol, Rome, Italy
[17] Univ Cattolica Sacro Cuore, Dept Woman Child & Publ Hlth, Rome, Italy
[18] Royal Marsden NHS Fdn Trust, London, England
[19] Inst Canc Res, London, England
[20] Clin Univ Navarra, Dept Gynaecol & Obstet, Canc Ctr, Navarra, Spain
[21] Charles Univ Prague, Fac Med 1, Dept Gynecol Obstet & Neonatol, Prague, Czech Republic
[22] Gen Univ Hosp Prague, Prague, Czech Republic
[23] Ist Europeo Oncol IRCCS, Dept Gynecol Oncol, Milan, Italy
[24] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy
[25] Bergonie Inst, Dept Biopathol, Bordeaux, France
[26] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gynecol Oncol, Div Canc Med, Oslo, Norway
[27] Hosp Civils Lyon, Inst Aging, Lyon, France
[28] Univ Lyon 1, CarMeN Lab, INSERM,U1060, INRAE,U1397,Hosp Civils Lyon, Pierre Benite, France
[29] Arbeitsgemeinschaft Gynakol Onkol AGO Study Grp, Ravensburg, Germany
[30] Univ Caen Normandy, Ctr Francois Baclesse, Dept Med Oncol, GINECO Grp, Caen, France
[31] CIBERONC, Hereditary Canc Program, Catalan Inst Oncol, ICO,IDIBELL, Barcelona, Spain
[32] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Obstet & Gynecol, Munich, Germany
[33] Univ Hosp Mannheim, Dept Obstet & Gynecol, Mannheim, Germany
[34] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany
[35] Belfast Hlth & Social Care Trust, Dept Pathol, Belfast, Antrim, North Ireland
[36] Gustave Roussy Canc Campus, Dept Gynecol Surg, Villejuif, France
[37] Hosp Univ Vall Hebron, Gynaecol Canc Programme, Vall Hebron Inst Oncol VHIO, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain
[38] Hosp Clin Univ, Dept Med Oncol, INCLIVA, CIBERONC, Valencia, Spain
[39] IRCCS Fdn Pascale, Ist Nazl Tumori Napoli, Dept Urol & Gynecol, Naples, Italy
[40] Houston Methodist Hosp, Dept Obstet & Gynecol, Houston, TX USA
[41] Univ Claude Bernard, Ctr Leon Berard, Dept Med Oncol, Lyon, France
[42] Inst Valenciano Oncol, Dept Med Oncol, Valencia, Spain
[43] North Eastern German Soc Gynecol Oncol NOGGO, Berlin, Germany
[44] Charite Berlin Univ Med, Ctr Oncol Surg, Dept Gynecol, Berlin, Germany
[45] Sheba Med Ctr, Ramat Gan, Israel
[46] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England
[47] City Hosp, Pan Birmingham Gynaecol Canc Ctr, Birmingham, W Midlands, England
[48] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[49] Natl Univ Singapore, Natl Univ Singapore NUS Ctr Canc Res, Yong Loo Lin Sch Med, Singapore, Singapore
[50] Natl Univ Singapore, Canc Sci Inst, Singapore, Singapore
关键词
chemotherapy; maintenance treatment; molecular biology; ovarian cancer; pathology; surgery; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; TUBAL INTRAEPITHELIAL CARCINOMA; SEROUS BORDERLINE TUMORS; NEOADJUVANT CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; ADJUVANT CHEMOTHERAPY; MAINTENANCE THERAPY; FALLOPIAN-TUBE; OPEN-LABEL; QUALITY INDICATORS;
D O I
10.1016/j.annonc.2023.11.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The European Society of Gynaecological Oncology, the European Society for Medical Oncology (ESMO) and the European Society of Pathology held a consensus conference (CC) on ovarian cancer on 15-16 June 2022 in Valencia, Spain. The CC panel included 44 experts in the management of ovarian cancer and pathology, an ESMO scientific advisor and a methodologist. The aim was to discuss new or contentious topics and develop recommendations to improve and harmonise the management of patients with ovarian cancer. Eighteen questions were identified for discussion under four main topics: (i) pathology and molecular biology, (ii) early -stage disease and pelvic mass in pregnancy, (iii) advanced stage (including older/frail patients) and (iv) recurrent disease. The panel was divided into four working groups (WGs) to each address questions relating to one of the four topics outlined above, based on their expertise. Relevant scientific literature was reviewed in advance. Recommendations were developed by the WGs and then presented to the entire panel for further discussion and amendment before voting. This manuscript focuses on the recommendation statements that reached a consensus, their voting results and a summary of evidence supporting each recommendation.
引用
收藏
页码:248 / 266
页数:19
相关论文
共 111 条
  • [1] Current Status of Metastatic Cardiophrenic Lymph Nodes (CPLNs) in Patients With Ovarian Cancer: A Review
    Acs, Miklos
    Piso, Pompiliu
    Prader, Sonia
    [J]. ANTICANCER RESEARCH, 2022, 42 (01) : 13 - 24
  • [2] Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting
    Amant, F.
    Berveiller, P.
    Boere, I. A.
    Cardonick, E.
    Fruscio, R.
    Fumagalli, M.
    Halaska, M. J.
    Hasenburg, A.
    Johansson, A. L. V.
    Lambertini, M.
    Lok, C. A. R.
    Maggen, C.
    Morice, P.
    Peccatori, F.
    Poortmans, P.
    Van Calsteren, K.
    Vandenbroucke, T.
    van Gerwen, M.
    van den Heuvel-Eibrink, M.
    Zagouri, F.
    Zapardiel, I.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (10) : 1601 - 1612
  • [3] Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy
    Amant, F.
    Vandenbroucke, T.
    Verheecke, M.
    Fumagalli, M.
    Halaska, M. J.
    Boere, I.
    Han, S.
    Gziri, M. M.
    Peccatori, F.
    Rob, L.
    Lok, C.
    Witteveen, P.
    Voigt, J-U
    Naulaers, G.
    Vallaeys, L.
    Van den Heuvel, F.
    Lagae, L.
    Mertens, L.
    Claes, L.
    Van Calsteren, K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19) : 1824 - 1834
  • [4] ESHRE guideline: female fertility preservation
    Anderson, Richard A.
    Amant, Frederic
    Braat, Didi
    D'Angelo, Arianna
    Lopes, Susana M. Chuva de Sousa
    Demeestere, Isabelle
    Dwek, Sandra
    Frith, Lucy
    Lambertini, Matteo
    Maslin, Caroline
    Moura-Ramos, Mariana
    Nogueira, Daniela
    Rodriguez-Wallberg, Kenny
    Vermeulen, Nathalie
    [J]. HUMAN REPRODUCTION OPEN, 2020, 2020 (04)
  • [5] [Anonymous], 2023, ECIS EUROPEAN CANC I
  • [6] Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients
    Armbrust, R.
    Chekerov, R.
    Sander, S.
    Biebl, M.
    Chopra, S.
    Krell, Jonathan
    Rinne, Natasha
    Nixon, Katherine
    Fotopoulou, C.
    Sehouli, J.
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 305 (04) : 963 - 968
  • [7] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [8] Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
    Boehm, Steffen
    Faruqi, Asma
    Said, Ian
    Lockley, Michelle
    Brockbank, Elly
    Jeyarajah, Arjun
    Fitzpatrick, Amanda
    Ennis, Darren
    Dowe, Thomas
    Santos, Jennifer L.
    Cook, Linda S.
    Tinker, Anna V.
    Le, Nhu D.
    Gilks, C. Blake
    Singh, Naveena
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (22) : 2457 - U73
  • [9] Adjuvant chemotherapy vs. observation in stage I clear cell ovarian carcinoma: A systematic review and meta-analysis
    Bogani, Giorgio
    Ditto, Antonino
    Lopez, Salvatore
    Bertolina, Francesca
    Murgia, Ferdinando
    Pinelli, Ciro
    Chiappa, Valentina
    Raspagliesi, Francesco
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 293 - 298
  • [10] Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses
    Bogani, Giorgio
    Tagliabue, Elena
    Ditto, Antonino
    Signorelli, Mauro
    Martinelli, Fabio
    Casarin, Jvan
    Chiappa, Valentina
    Dondi, Giulia
    Maggiore, Umberto Leone Roberti
    Scaffa, Cono
    Borghi, Chiara
    Montanelli, Luca
    Lorusso, Domenica
    Raspagliesi, Francesco
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 61 - 65